Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-PHENO-27278

Xla + Tebucur [5mg/L], Ihle V et al. (2025)

Experiment + Assay: Xla + Tebucur [5mg/L] + NF44-45 (immunohistochemistry)
Background: Xla.Portsmouth1EXRC
Conditions:
Assay Type Assay Stages Antibody
immunohistochemistry NF stage 44 to NF stage 45  
Anatomical Phenotypes: abnormal heart morphology, decreased size of the heart
Expression Phenotypes (1):
decreased amount tnnt2.L expression in cardiac mesoderm
Source: Fig. 5 b
Article: XB-ART-61367, PubMed